Grand Pharmaceutical Group Limited (HKG:0512)
8.41
+0.05 (0.60%)
Sep 29, 2025, 11:58 AM HKT
HKG:0512 Revenue
Grand Pharmaceutical Group had revenue of 6.11B HKD in the half year ending June 30, 2025, with 1.97% growth. This brings the company's revenue in the last twelve months to 11.70B, up 10.56% year-over-year. In the year 2024, Grand Pharmaceutical Group had annual revenue of 11.64B with 10.59% growth.
Revenue (ttm)
11.70B
Revenue Growth
+10.56%
P/S Ratio
2.50
Revenue / Employee
976.47K
Employees
11,987
Market Cap
29.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.64B | 1.12B | 10.59% |
Dec 31, 2023 | 10.53B | 967.31M | 10.12% |
Dec 31, 2022 | 9.56B | 964.31M | 11.22% |
Dec 31, 2021 | 8.60B | 2.25B | 35.34% |
Dec 31, 2020 | 6.35B | -237.72M | -3.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
JD Health International | 71.34B |
Hansoh Pharmaceutical Group Company | 14.45B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |